"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A1,US 2011/0262387 A1,012-533-327-775-404,2011-10-27,2011,US 201113016607 A,2011-01-28,US 201113016607 A;;US 29906110 P,2010-01-28,METHODS AND MATERIALS FOR REDUCING OR SUPPRESSING AMYLOID DEPOSITION,"This document relates to methods and materials for treating diseases and disorders that are caused by or associated with amyloid or amyloid-like proteins, such as Alzheimer's disease. For example, methods and materials for using interleukin-6 to reduce or suppress the deposition of Aβ are provided.",DAS PRITAM;;GOLDE TODD E;;CHAKRABARTY PARAMITA,DAS PRITAM;;GOLDE TODD E;;CHAKRABARTY PARAMITA,MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (2011-02-04),https://lens.org/012-533-327-775-404,Patent Application,yes,2,1,1,1,2,A61K48/005;;A61K48/005;;A61K38/204;;A61K38/204;;A61P25/28;;C12N2799/025;;C12N2799/025,A61K38/20;;A61K48/00;;A61P25/28,424/85.2;;X514 44  R,6,6,107-876-252-686-587;;096-984-362-931-695;;029-431-436-415-74X;;020-147-546-720-408;;033-059-699-280-310;;008-548-990-768-689,7554393;;10.1111/j.1365-2249.1995.tb06659.x;;pmc1553348;;19825975;;pmc3083918;;10.1096/fj.09-141754;;10.1016/0304-3940(95)11384-9;;7783982;;18701698;;10.1523/jneurosci.0616-08.2008;;pmc2597474;;11279286;;10.1046/j.1471-4159.2001.t01-1-00240.x;;pmc1851864;;17255335;;10.2353/ajpath.2007.060378,"Banks, RE et al. (1995) The acute phase protein response in patients receiving subcutaneous IL-6. Clin. Exp. Immunol. 102:217-223.;;Chakrabarty P et al. (2010) Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J. 24:548-559.;;Del Bo R et al. (1995) Reciprocal control of inflammatory cytokies, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci. Lett. 188:70-74.;;Hickman SE et al. (2008) Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci. 28(33):8354-8360.;;Szczepanik AM et al. (2001) Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo. J. Neurochem. 77:304-317.;;Yamamoto M et al. (2007) Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am. J. Pathol. 170(2):680-692.",DISCONTINUED
2,US,B2,US 8745748 B2,052-214-722-747-385,2014-06-03,2014,US 90595610 A,2010-10-15,US 90595610 A,2010-10-15,Cancelling digital signatures for form files,"The embodiments described herein generally relate to methods and systems for enabling a client to request a server to cancel the digital signing of a form file associated with a form. Successful cancellation of the digital signing process results in a return of the form file to its initial state, in which data are not lost, and the form can be resubmitted and/or the application of the digital signature can be retried. Request and response messages, communicated between a protocol client and a protocol server, cause the performance of protocol functions for applying a digital signature to a form file and for cancelling the signature thereof where errors in the signing process are detected. A versioning mechanism enabling the detection of version differences and resulting upgrades to the digital signature control allows for robust communications between a client and a server operating under different product versions.",IFRIM SILVIU;;DAS PARAMITA;;BROTSOS CHRISTOPHER A;;SCHOFIELD PAUL MICHAEL;;MICROSOFT CORP,IFRIM SILVIU;;DAS PARAMITA;;BROTSOS CHRISTOPHER A;;SCHOFIELD PAUL MICHAEL,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2014-02-24),https://lens.org/052-214-722-747-385,Granted Patent,yes,23,0,2,2,0,G06F21/64;;H04L63/12;;H04L63/12;;G06F21/64,G06F7/00,726/26;;709/203;;709/224;;717/140;;726/10;;726/27;;726/28;;713/156;;705/34;;705/51;;705/63,5,0,,,"Anderson, Steve et al., ""Web Services Secure Conversation Language (WS-SecureConversation)"" Feb. 2005, Retrieved from: , (31 pages).;;Cameron, Stefan, ""Building intelligent forms using Adobe LiveCycle Designer,"" Oct. 2008, Retrieved from: , (9 pages).;;Orchard, David, et al. ""Versioning XML Languages,"" Oct. 2003, Retrieved from: , (27 pages).;;Templeton, Brad, ""How to authenticate cancel messages today,"" [Retrieved on May 7, 2010], Retrieved from: , (4 pages).;;Tobarra, Llanos, et al. ""Analysis of Web Services Secure Conversation with Formal Methods,"" 2007, Retrieved from: , (6 pages).",ACTIVE
3,US,A1,US 2012/0096559 A1,115-090-085-160-734,2012-04-19,2012,US 90595610 A,2010-10-15,US 90595610 A,2010-10-15,CANCELLING DIGITAL SIGNATURES FOR FORM FILES,"The embodiments described herein generally relate to methods and systems for enabling a client to request a server to cancel the digital signing of a form file associated with a form. Successful cancellation of the digital signing process results in a return of the form file to its initial state, in which data are not lost, and the form can be resubmitted and/or the application of the digital signature can be retried. Request and response messages, communicated between a protocol client and a protocol server, cause the performance of protocol functions for applying a digital signature to a form file and for cancelling the signature thereof where errors in the signing process are detected. A versioning mechanism enabling the detection of version differences and resulting upgrades to the digital signature control allows for robust communications between a client and a server operating under different product versions.",IFRIM SILVIU;;DAS PARAMITA;;BROTSOS CHRISTOPHER A;;SCHOFIELD PAUL MICHAEL;;MICROSOFT CORP,IFRIM SILVIU;;DAS PARAMITA;;BROTSOS CHRISTOPHER A;;SCHOFIELD PAUL MICHAEL,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2014-02-24),https://lens.org/115-090-085-160-734,Patent Application,yes,20,2,2,2,0,G06F21/64;;H04L63/12;;H04L63/12;;G06F21/64,G06F21/00,726/26,0,0,,,,ACTIVE
